Structural Insights into Arl1-Mediated Targeting of the Arf-GEF BIG1 to the trans-Golgi

• Arl1 binds the N-terminal DCB domain of the Arf1-GEF BIG1
• Structure of the human DCBBIG1/Arl1 complex is solved at 2.3 Å resolution
• The Arl1 binding surface on the DCB domain is unrelated to known Arl1 effectors
• Structure-guided mutation shows BIG1 needs Ar11 binding for Golgi targeting

SummaryThe GTPase Arf1 is the major regulator of vesicle traffic at both the cis- and trans-Golgi. Arf1 is activated at the cis-Golgi by the guanine nucleotide exchange factor (GEF) GBF1 and at the trans-Golgi by the related GEF BIG1 or its paralog, BIG2. The trans-Golgi-specific targeting of BIG1 and BIG2 depends on the Arf-like GTPase Arl1. We find that Arl1 binds to the dimerization and cyclophilin binding (DCB) domain in BIG1 and report a crystal structure of human Arl1 bound to this domain. Residues in the DCB domain that bind Arl1 are required for BIG1 to locate to the Golgi in vivo. DCB domain-binding residues in Arl1 have a distinct conformation from those in known Arl1-effector complexes, and this plasticity allows Arl1 to interact with different effectors of unrelated structure. The findings provide structural insight into how Arf1 GEFs, and hence active Arf1, achieve their correct subcellular distribution.

Graphical AbstractFigure optionsDownload as PowerPoint slide